D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine.
Ontology highlight
ABSTRACT: Functionally selective G protein-coupled receptor ligands are valuable tools for deciphering the roles of downstream signaling pathways that potentially contribute to therapeutic effects versus side effects. Recently, we discovered both Gi/o-biased and β-arrestin2-biased D2 receptor agonists based on the Food and Drug Administration (FDA)-approved drug aripiprazole. In this work, based on another FDA-approved drug, cariprazine, we conducted a structure-functional selectivity relationship study and discovered compound 38 (MS1768) as a potent partial agonist that selectively activates the Gi/o pathway over β-arrestin2. Unlike the dual D2R/D3R partial agonist cariprazine, compound 38 showed selective agonist activity for D2R ov
SUBMITTER: Shen Y
PROVIDER: S-EPMC6509010 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
ACCESS DATA